Quarterly report · Q1
7745.TEDINET S100OYU3
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥51.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | −¥219m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥847m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | −¥1m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥956m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥6m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥957m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥159m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥570m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥153m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥698m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥64.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥59.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥53.9bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥32.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥23.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.7bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-5.83 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.92 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.64 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥172.66 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.58 | 2021-04-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.9% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 97
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥1.6bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥18m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥102m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥116m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥917m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥175m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.5bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥132m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥124m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥231m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥230m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥10m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥131m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥15m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥652m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥7.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥272m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥10.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥792m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥4.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥4.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥294m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥875m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥822m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥52m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥81m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.8bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.8bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥3m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥45m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥606m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥117m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥166m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥8m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥212m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥212m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥4m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥130m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥3.3bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥587m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥184m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥535m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥407m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥6.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥5.4bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥14m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥8.3bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥4.9bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥720m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥407m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 450
| Item | Context | Value | Unit |
|---|---|---|---|
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社エー・アンド・デイ | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都豊島区東池袋三丁目23番14号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding allowances directly deducted from balances of assets (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding financial covenants (text) | CurrentQuarterInstant | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |